When you are getting a dental implant, you are likely to hear brand names — Straumann, Nobel Biocare, Osstem, Dentium. Your dentist may recommend one over another. You may see different prices depending on which brand is used. What do these differences actually mean, clinically?
This article explains what an implant brand represents, what differentiates the major systems used in Malaysia, what the published survival data shows for each, and what matters most for long-term success.
Why titanium — and how the implant biology works
All modern dental implant fixtures are made from titanium or a titanium-based alloy. The use of titanium in implants stems from a chance discovery by Swedish anatomy professor Per-Ingvar Brånemark in the 1950s. While studying microcirculation in bone using titanium optical chambers, he found that the titanium had permanently fused with the surrounding bone and could not be removed without damaging the tissue. He termed this phenomenon osseointegration — from the Latin os (bone) and integro (to make whole).
Brånemark placed the first titanium dental implant in a human patient in 1965. The system was commercialised and introduced to the market by what would become Nobel Biocare in 1982. By the late 1980s, implant dentistry had become an international clinical standard, applied millions of times worldwide.
Osseointegration works because of titanium's unique surface chemistry. The metal forms a spontaneous oxide layer (primarily titanium dioxide) on contact with air or biological fluids. This oxide surface is biocompatible — it does not trigger a significant immune response — and osteoblasts (bone-forming cells) adhere to it and deposit new bone matrix directly onto the titanium surface. Over weeks to months, this bone matures and mineralises, firmly anchoring the implant.
What actually differs between brands
All reputable implant systems use medical-grade titanium. The meaningful differences between brands are:
- Material grade: Most use Grade 4 commercially pure titanium (cpTi). Some premium systems use titanium alloys — Straumann's Roxolid is a titanium-zirconium alloy with higher tensile strength, allowing smaller-diameter implants without compromising structural integrity.
- Surface treatment: The micro-texture of the implant surface influences how quickly osteoblasts attach and how rapidly osseointegration proceeds. Surface treatments range from sandblasting and acid-etching (SLA, used by Straumann) to oxidised surfaces (TiUnite, used by Nobel Biocare) to hydrophilic-modified surfaces (SLActive, Straumann).
- Published clinical evidence: The breadth and duration of peer-reviewed follow-up data varies considerably between brands. Premium European brands have the most extensive published long-term data.
- Prosthetic component compatibility: Different brands use different connection geometries (internal hex, conical connection, Morse taper). The precision and fit of the implant-abutment connection influences mechanical stability and the risk of micro-leakage at the interface over time.
The major brands used in Malaysia: what the data shows
Straumann (Switzerland)
Material: Roxolid (Ti-Zr alloy) or Grade 4 cpTi Surface: SLA / SLActive 10-year survival: >95–96%Straumann is a Swiss company and one of the most clinically studied implant systems in the world. Its standard surface treatment, SLA (sandblasted, large-grit, acid-etched), produces a micro-rough surface that promotes osteoblast adhesion. The modified version, SLActive (chemically treated to be hydrophilic), is reported to accelerate osseointegration, reducing the standard healing period from 6–8 weeks to as little as 3–4 weeks in suitable cases.
Its Roxolid alloy (approximately 15% zirconium, 85% titanium) provides higher tensile strength than commercially pure titanium, allowing narrower-diameter implants in sites with limited bone width. Published data from the ITI (International Team for Implantology) consistently show survival rates exceeding 95% at 10 years, with many cohort studies reporting above 96%.
Nobel Biocare (Sweden)
Material: Grade 4 commercially pure titanium Surface: TiUnite (oxidised) 10-year survival: >95%Nobel Biocare is the company that commercialised Brånemark's original implant system in 1982 under what was then Nobelpharma. It is historically the most influential brand in implant dentistry. Its TiUnite surface is an oxidised titanium surface with a thickened oxide layer and increased surface porosity, designed to maximise bone-to-implant contact at early healing stages.
Nobel Biocare developed the All-on-4® treatment concept in partnership with Dr. Paulo Malo. It offers a wide range of implant diameters and prosthetic connection options. Published 10-year survival data for Nobel Biocare implants consistently exceed 95%, comparable to Straumann.
Osstem (South Korea)
Material: Grade 4 commercially pure titanium Surface: HA-coated or SLA-type 7-year survival: 95.37% (Kim et al., 2014)Osstem is the largest implant manufacturer in Asia by volume and one of the most widely used brands across South Korea, Southeast Asia, and China. It uses Grade 4 commercially pure titanium with a surface treatment comparable to SLA in most of its product lines.
A 7-year retrospective clinical study published in the International Journal of Oral and Maxillofacial Implants (Kim et al., 2014; PMC4028788) reported a cumulative survival rate of 95.37% for Osstem implants. This is within the clinically accepted range for implant success and comparable to the lower range of published data for premium European systems at equivalent follow-up periods.
Osstem implants are generally priced below premium European brands, making them a common choice in cost-sensitive cases across Malaysian private clinics.
Dentium / Implantium (South Korea)
Material: Grade 4 and Grade 5 titanium Surface: SA (sandblasted and acid-etched) 10-year survival: 97.9% (Lee et al., 2017)Dentium is a South Korean manufacturer that produces the Implantium system, among others. A 10-year retrospective clinical study published in the Journal of Periodontal and Implant Science (Lee et al., 2017; PMC5483406) reported a cumulative survival rate of 97.9% for Implantium implants over a 10-year follow-up — comparable to the performance of premium European systems over the same period in that study cohort.
Dentium uses a combination of Grade 4 (commercially pure) and Grade 5 (Ti-6Al-4V alloy) titanium depending on the implant line. Its SA (sandblasted and acid-etched) surface treatment is similar in concept to Straumann's SLA.
Comparing published survival data
| Brand | Origin | Longest published survival data | Survival rate |
|---|---|---|---|
| Straumann | Switzerland | 10+ years (multiple cohorts) | >95–96% |
| Nobel Biocare | Sweden | 10+ years (multiple cohorts) | >95% |
| Osstem | South Korea | 7 years (Kim et al., 2014) | 95.37% |
| Dentium / Implantium | South Korea | 10 years (Lee et al., 2017) | 97.9% |
What matters most for implant success
The implant brand matters — but it is not the only variable, and arguably not the most important one. The clinical literature consistently identifies the following as the primary determinants of implant success:
- Patient selection: Uncontrolled diabetes, heavy smoking, unresolved periodontal disease, and insufficient bone volume all significantly increase failure risk, regardless of which implant brand is used.
- Pre-surgical planning: Accurate CBCT imaging is associated with safer and more precise implant placement. An implant placed without imaging into bone that does not have sufficient dimensions is at higher risk of failure regardless of its brand.
- Surgical technique: The clinician's experience and precision during placement — including drilling speed, irrigation, torque, and the achievement of primary stability — is a major predictor of osseointegration.
- Loading protocol: Immediate loading (fitting the crown the same day as surgery) is clinically appropriate only in specific cases with high primary implant stability. Premature loading of an implant that has not yet integrated is a common cause of failure.
- Oral hygiene and maintenance: Peri-implantitis — inflammation of the tissue around an implant — is the leading cause of late implant failure. It is preventable with good daily oral hygiene and regular professional cleaning.
A well-placed Korean implant in a healthy patient with good bone and excellent oral hygiene will outperform a premium European implant placed poorly in a high-risk patient. Brand selection is meaningful — but it is one factor among several.
Questions to ask your dentist about implant brand
- Which brand and model of implant will you use, and why do you prefer it?
- Does the brand have published peer-reviewed survival data? At what follow-up period?
- Does the brand have global distribution for replacement parts and components if needed in 10–15 years?
- Is this an established brand, or a low-cost unbranded fixture?
Key Takeaways
- Titanium's biocompatibility was discovered by Per-Ingvar Brånemark in the 1950s; the first human implant was placed in 1965
- All reputable implant brands use medical-grade titanium; differences lie in alloy composition, surface treatment, and the extent of published clinical data
- Straumann (SLActive surface) and Nobel Biocare (TiUnite surface) are the most extensively studied systems, with 10-year survival rates consistently above 95%
- Osstem (Korea) has a published 7-year survival rate of 95.37%; Dentium Implantium has a published 10-year survival rate of 97.9%
- Brand choice is meaningful, but surgical technique, CBCT planning, patient health, and long-term oral hygiene are equally or more important determinants of implant success
- Avoid unbranded, uncertified implant components — the absence of published survival data is a genuine clinical risk
At Koo Dental Clinic in Taman Connaught, Cheras, we use internationally recognised implant systems with documented clinical track records. At your free CBCT consultation, we will explain which brand we recommend for your case and why — including the published data for that system.